Noncosmetic uses of botulinum toxin

Clinics in Dermatology

Volumn 22, Issue 1, 2004, Pages 82-88

  Bentsianov, Boris ^b   Zalvan, Craig ^b   Blitzer, Andrew ^a  

^a New York Center for Voice and Swallowing Disorders   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ANUS DISEASE; ANUS FISSURE; APRAXIA; BLEPHAROSPASM; BRUXISM; CONSTIPATION; CONVERGENT STRABISMUS; DIVERGENT STRABISMUS; DUANE RETRACTION SYNDROME; DYSPHONIA; DYSTONIA; ESOPHAGUS ACHALASIA; ESSENTIAL TREMOR; EYE DISEASE; FREY SYNDROME; GASTROINTESTINAL DISEASE; GRANULOMA; HEMIFACIAL SPASM; HICCUP; HUMAN; HYPERSALIVATION; LARYNX DISORDER; MEIGE DISEASE; MIGRAINE; MORBID OBESITY; MUSCLE CRAMP; MUSCLE HYPERTROPHY; MYOCLONUS; MYOFASCIAL PAIN; MYOKYMIA; NYSTAGMUS; OSCILLOPSIA; PAIN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPASTICITY; STOMACH PARESIS; STRABISMUS; STUTTERING; SYNKINESIS; TENSION HEADACHE; URINE RETENTION; UROGENITAL TRACT DISEASE; VAGINISM;

EID: 2442637456     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2003.12.030     Document Type: Article

References (84)

1. Braun V., Richter H.P. Selective peripheral denervation for spasmodic torticollis 13-year experience with 155 patients. J Neurosurg. 97:(suppl 2):2002;207-212
2. Blitzer A., Brin M.F., Greene P.E., et al. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol. 98:1989;93-97
3. Blitzer A., Brin M.F., Fahn S. Botulinum toxin injections for lingual dystonia. Laryngoscope. 101:1991;799-810
4. Defazio G., Abbruzzese G., Girlanda P., et al. Botulinum toxin A treatment for primary hemifacial spasm a 10-year multicenter study. Arch Neurol. 59:2002;418-420
5. Taylor J.D., Kraft S.P., Kazdan M.S., et al. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin a Canadian multicentre study. Can J Ophthalmol. 26:1991;133-138
6. Bertolasi L., Priori A., Tomelleri G., et al. Botulinum toxin treatment of muscle cramps a clinical and neurophysiological study. Ann Neurol. 41:1997;181-186
7. Tsui J.K., Bhatt M., Calne S., et al. Botulinum toxin in the treatment of writer's cramp a double-blind study. Neurology. 43:1993;183-185
8. Wissel J., Kabus C., Wenzel R., et al. Botulinum toxin in writer's cramp objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry. 61:1996;172-175
9. Wong V., Ng A., Sit P. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy. J Child Neurol. 17:2002;138-142
10. Brashear A., Gordon M.F., Elovic E., et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 347:2002;395-400
11. Sedano M.J., Trejo J.M., Macarron J.L., et al. Continuous facial myokymia in multiple sclerosis treatment with botulinum toxin. Eur Neurol. 43:2000;137-140
12. Jordan D.R., Anderson R.L., Thiese S.M. Intractable orbicularis myokymia treatment alternatives. Ophthalmic Surg. 20:1989;280-283
13. Nix W.A., Butler I.J., Roontga S., et al. Persistent unilateral tibialis anterior muscle hypertrophy with complex repetitive discharges and myalgia report of two unique cases and response to botulinum toxin. Neurology. 42:1992;602-606
14. Srirompotong S., Tiamkao S., Jitpimolmard S. Botulinum toxin injection for objective tinnitus from palatal myoclonus a case report. J Med Assoc Thai. 85:2002;392-395
15. Lagueny A., Tison F., Burbaud P. Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A. Mov Disord. 14:1999;182-185
16. Laskawi R, Damenz W, Roggenkamper P. Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol 1994;23:S195-9
17. Blitzer A, Zalvan C, Gonzalez-Yanes O, et al. Botulinum toxin injections for the management of the hyperfunctional larynx. In: Brin MF, Jancovic J, Hallett M, editors. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins, 2002
18. Blitzer A., Brin M.F., Stewart C. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia) a 12-year experience in more than 900 patients. Laryngoscope. 108:1998;1435-1441
19. Nasri S., Sercarz J.A., McAlpin T., et al. Treatment of vocal fold granuloma using botulinum toxin type A. Laryngoscope. 105:1995;585-588
20. Wani M.K., Woodson G.E. Laryngeal contact granuloma. Laryngoscope. 109:1999;1589-1593
21. Woodson G.E., Murry T. Botulinum toxin in the treatment of recalcitrant mutational dysphonia. J Voice. 8:1994;347-351
22. Nathan C.O., Yin S., Stucker F.J. Botulinum toxin adjunctive treatment for posterior glottic synechiae. Laryngoscope. 109:1999;855-857
23. Ptok M., Schonweiler R. Botulinum toxin type A-induced "rebalancing" in bilateral vocal cord paralysis. HNO. 49:2001;548-552
24. Brin M.F., Stewart C., Blitzer A., et al. Laryngeal botulinum toxin injections for disabling stuttering in adults. Neurology. 44:1994;2262-2266
25. Zormeier M.M., Meleca R.J., Simpson M.L. Botulinum toxin injection to improve tracheoesophageal speech after total laryngectomy. Otolaryngol Head Neck Surg. 120:1999;314-319
26. Blitzer A., Komisar A., Baredes S., et al. Voice Failures after tracheoesophageal puncture management with botulinum toxin. Otolaryngol Head Neck Surg. 113:1995;668-671
27. Warrick P., Dromey C., Irish J.C., et al. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor a crossover design study of unilateral versus bilateral injection. Laryngoscope. 110:2000;1366-1374
28. Salloway S., Stewart C.F., Israeli L., et al. Botulinum toxin for refractory vocal tics. Mov Disord. 11:1996;746-748
29. Blitzer A., Brin M.F. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg. 116:1997;328-330
30. Binder W.J., Brin M.F., Blitzer A., et al. Botulinum toxin type A (Botox) for treatment of migraine headaches an open-label study. Otolaryngol Head Neck Surg. 123:2000;669-676
31. Silberstein S., Mathew N., Saper J., et al. Botulinum toxin type A as a migraine preventive treatment. For the Botox Migraine Clinical Research Group. Headache. 40:2000;445-450
32. Freund B.J., Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A a pilot study. Headache. 40:2000;231-236
33. Foster L., Clapp L., Erickson M., et al. Botulinum toxin A and chronic low back pain a randomized, double-blind study. Neurology. 56:2001;1290-1293
34. Carruthers J.D.A. The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus. 32:1995;306-308
35. Scott A.B. Botulinum toxin injection of the eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 79:1981;734-770
36. Harris G., Dawson E., Lee J. Botulinum toxin to the lateral rectus for the treatment of esotropia with paradoxical diplopia. Strabismus. 9:2001;79-82
37. Dawson E.L., Marshman W.E., Adams G.G. The role of botulinum toxin A in acute-onset esotropia. Ophthalmology. 106:1999;1727-1730
38. Chalzislefanov K.I., Mills M.D. The role of drug treatment in children with strabismus and amblyopia. Pediatr Drugs. 2:2000;91-100
39. Wuebolt G.E., Drummond G. Temporary tarsorrhaphy induced with type A botulinum toxin. Can J Ophthalmol. 26:1991;383-385
40. Sablin S., Chen E., Kaugesnar T., et al. Effect of eyelid botulinum tosin injection on lacrimal drainage. Am J Ophthalmol. 129:2000;481-486
41. Chang L.B., Tsai C.P., Liao K.K., et al. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm. Zhongua Yi Xue Za Shi (Taipei). 62:1999;1-5
42. Chapman K.L., Bartley G.B., Waller R.R., Hodge D.O. Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995. Ophthal Plast Reconstr Surg. 15:1999;106-110
43. Mezaki T., Kaji R., Brin M.F., et al. Combined use of the A and B botulinum toxins for blepharospasm a double-blind controlled trial. Mov Disord. 14:1999;1017-1020
44. Campos E. Strabismus and ocular motility disorders. In Proceedings of the Sixth Meeting of the International Strabismological Association. Surfer's Paradise. 1990;MacMillan Press, Australia. 221-235
45. Lennerstrand G., Nordbo O.A., Tian S., et al. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 76:1998;27-27
46. Ruben S.T., Lee J.P., O'Neil D., et al. The use of botulinum toxin for treatment of acquired nystagmus and oscillopsia. Ophthalmology. 101:1994;783-787
47. Helveston E.M., Pogrebniak A.E. Treatment of acquired nystagmus with botulinum toxin A. Am J Ophthalmol. 106:1988;584-586
48. Repka M.X., Savino P.J., Reinecke R.D. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol. 112:1994;1320-1324
49. Lawson J.M., Kousoulides L., Lee J.P. Long-term results of botulinum toxin in consecutive and secondary exotropia outcome in patients initially treated with botulinum toxin. J AAPOS. 2:1998;195-200
50. Keegan D.J., Geerling G., Lee J.P., et al. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol. 86:2002;43-46
51. Dulguerov P., Qinodoz D., Cosendal G., et al. Frey syndrome treatment with botulinum toxin. Otol Head Neck Surg. 122:2000;821-827
52. Laccourreye O., Akl E., Gutierrez-Fonseca R., et al. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A incidence, management and outcome. Arch Otolaryngol Head Neck Surg. 125:1999;283-286
53. Arad-Cohen A., Blitzer A. Botulinum toxin treatment for symptomatic Frey's syndrome. Otolaryngol Head Neck Surg. 122:2000;237-240
54. Vargas H., Galati L.T., Panes S.M. A pilot study evaluating the treatment of postparotidectomy sialoceles with botulinum toxin type A. Arch Otol Head Neck Surg. 126:2000;421-424
55. Gless R., Nauman M., Werner B., et al. Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 69:2000;121-123
56. Suskind D.L., Tilton A. Clinical Study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 112:2002;73-78
57. Guntinas-Lichius O., Sittel C. Treatment of postparotidectomy salivary fistula with botulinum toxin. Ann Otol Rhinol Laryngol. 110:2001;1162-1164
58. Akkoc Y., Kirazli Y., Ozyurt C., et al. Effects of botulinum toxin on detrusor-sphincter dyssynergia in patients with multiple sclerosis. BJU Int. 86:2000;754-776
59. Phelan M.W., Franks M., Somogyi G.T., et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 165:2001;1107-1110
60. Schurch B., Stohrer M., Krainer G., et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients a new alternative to anticholinergic drugs? J Urol. 164:2000;692-697
61. Brin M.F., Vapnek J.M. Treatment of vaginismus with botulinum toxin injections. Lancet. 349:2000;656
62. Tan E.K., Jankovic J. Tardive and idiopathic oromandibular dystonia a clinical comparison. J Neurol Neurosurg Psychiatry. 68:2000;186-190
63. Tan E.K., Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 131:2000;211-216
64. To E.W., Ahuja A.T., Ho W.S., et al. A prospective study of the effect of botulinum toxin on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg. 54:2001;197-200
65. Freund B., Schwartz M., Symington J.M. Botulinum toxin new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 38:2000;466-471
66. Neubrand M., Scheurlen C., Schepke M., et al. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy. 34:2002;519-523
67. DaSilveira E.B., Rogers A.I. Treatment of achalasia with botulinum toxin. Am J Ther. 9:2002;157-161
68. Minguez M., Melo F., Espi A. Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum. 42:1999;1016-1021
69. Maria G., Brisinda G., Bentivoglio A.R. Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure long-term results after two different dosage regimens. Ann Surg. 228:1998;664-669
70. Minkes RK, Langer JC. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease. J Pediatr Surg 2000;35:1733-6
71. Maria G., Brisinda G., Bentivoglio A.R., et al. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum. 43:2000;376-380
72. Hawley P. Botulinum toxin for severe anorectal pain. J Pain Symptom Manage. 24:2002;11-12
73. Ron Y., Avni Y., Lukovetski A., et al. Botulinum toxin type-A in the therapy of patients with anismus. Dis Colon Rectum. 44:2001;1821-1826
74. Miller L.S., Szych G.A., Kantor S.B., et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol. 97:2002;1653-1660
75. Ezzeddine D., Jit R., Katz N., et al. Pyloric injections of botulinum toxin for the treatment of diabetic gastroparesis. Gastrointest Endosc. 55:2002;920-923
76. Wehrman T., Schmitt T.H., Arndt A., et al. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction. Aliment Pharmocol Ther. 14:2000;1469-1477
77. Wehrman T., Seifert H., Seipp M., et al. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy. 30:1998;702-707
78. Devault K.R. Dysphagia from esophageal diverticulosis responding to botulinum toxin injection. Am J Gastroenterol. 92:1997;895-897
79. Whatling P.J., Collin J. Botulinum toxin injection is an effective treatment for axillary hyperhidrosis. Br J Surg. 88:2001;814-815
80. Glogau R.G. Botulinum A neurotoxin for axillary hyperhidrosis. Dermatol Surg. 24:1998;817-819
81. Glogau R.G. Treatment of palmer hyperhidrosis with botulinum toxin. Semin Cut Med Surg. 20:2001;101-108
82. Rohrbach S., Olthoff A., Laskawi R., et al. Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol. 110:2001;1045-1050
83. Shaari C.M., Sanders I., Wu B.L., et al. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head and Neck Surg. 112:1995;566-571
84. Bushara M.A., Bushara K. Botulinum toxin, sweating, and body odor. N Engl J Med. 347:2002;620-621